Search

everythinglearnresearchcommunity

for

Search:↓

OXTR agonists may promote hair growth and be effective for treating hair loss.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The transition from growth to regression in Cashmere goat hair follicles involves changes in expression of genes related to keratin and cell differentiation.

Scientists found genes linked to the growth of high-quality brush hair in Chinese Haimen goats.

The study created hair-bearing skin models that lack a key protein for skin layer attachment, limiting their use for certain skin disease research.

Cells from certain embryo parts can induce head formation in another embryo, involving complex signaling pathways.

Tight junctions create a barrier in pig hair follicles that controls what can enter the skin.

Wnt ligands, produced by dermal papilla cells, are essential for adult hair growth and regeneration.

Enzymes play crucial roles in metabolism, health, and disease management.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

A 28-year-old man with type 1 diabetes had skin and hair issues due to zinc deficiency.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Wnt5a slows down hair growth by blocking a specific pathway during hair regeneration.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Key genes linked to hair growth and cancer were identified in hairless mice.